India, Feb. 13 -- image credit- freepik

W Health Ventures has announcedthe initial close of Fund II at Rs 550 crore, aiming toward a target of Rs 630 crore. The firm will continue to double down on its company creation model by building and scaling healthcare companies from scratch in India and across the US-India corridor.

W Health Ventures' Fund I companies include Nivaan (chronic pain), BeatO (diabetes), ElevateNow (obesity), BabyMD (paediatrics), and Mylo (parenting) in India, along with cross-border companies like Wysa (AI mental health services) and Reveal HealthTech (AI transformation services). All Fund I companies have raised external growth capital.

With Fund II, W Health Ventures expects to take larger, bolder bets on compan...